Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats

Kazuyuki Fuji, Masayuki Hiramatsu, Tsutomu Kameyama, Toshitaka Nabeshima

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The effects of repeated propentofylline administration on impairments of learning and memory in rats with basal forebrain lesions were investigated in several behavioral tasks (water maze, habituation and passive avoidance tasks). Rats were subjected to all the tasks in sequence. Basal forebrain lesions produced by bilateral injections of ibotenic acid (approximately 6 μg on each side) severely impaired performance in water maze, habituation and passive avoidance tasks. Repeated administration of propentofylline (10 and 25 mg/kg per day for 14 days, p.o.) improved the deficits of performance in a water maze task, even when administration began one week after the basal forebrain lesions were produced. The impaired performance in habituation and passive avoidance tasks was also markedly ameliorated after repeated administration (24 and 26 days) of propentofylline. The rats with basal forebrain lesions exhibited a significant decrease in choline acetyltransferase activity in the cortex. Propentofylline significantly increased hippocampal choline acetyltransferase activity in basal forebrain-lesioned rats compared with that in vehicle-treated basal forebrain-lesioned rats. However, cortical choline acetyltransferase activity in basal forebrain-lesioned animals was not affected by repeated propentofylline administration. These results indicate that repeated administration of this agent ameliorated the impaired performance of basal forebrain-lesioned rats in part by increasing hippocampal choline acetyltransferase activity. Propentofylline might be useful for the treatment of amensia and dementia.

Original languageEnglish
Pages (from-to)411-417
Number of pages7
JournalEuropean Journal of Pharmacology
Volume236
Issue number3
DOIs
Publication statusPublished - 04-06-1993
Externally publishedYes

Fingerprint

Choline O-Acetyltransferase
Water
Ibotenic Acid
propentofylline
Basal Forebrain
Dementia
Learning
Injections
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

@article{0cd93afd65ac4f799bb31e2c2d6583f3,
title = "Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats",
abstract = "The effects of repeated propentofylline administration on impairments of learning and memory in rats with basal forebrain lesions were investigated in several behavioral tasks (water maze, habituation and passive avoidance tasks). Rats were subjected to all the tasks in sequence. Basal forebrain lesions produced by bilateral injections of ibotenic acid (approximately 6 μg on each side) severely impaired performance in water maze, habituation and passive avoidance tasks. Repeated administration of propentofylline (10 and 25 mg/kg per day for 14 days, p.o.) improved the deficits of performance in a water maze task, even when administration began one week after the basal forebrain lesions were produced. The impaired performance in habituation and passive avoidance tasks was also markedly ameliorated after repeated administration (24 and 26 days) of propentofylline. The rats with basal forebrain lesions exhibited a significant decrease in choline acetyltransferase activity in the cortex. Propentofylline significantly increased hippocampal choline acetyltransferase activity in basal forebrain-lesioned rats compared with that in vehicle-treated basal forebrain-lesioned rats. However, cortical choline acetyltransferase activity in basal forebrain-lesioned animals was not affected by repeated propentofylline administration. These results indicate that repeated administration of this agent ameliorated the impaired performance of basal forebrain-lesioned rats in part by increasing hippocampal choline acetyltransferase activity. Propentofylline might be useful for the treatment of amensia and dementia.",
author = "Kazuyuki Fuji and Masayuki Hiramatsu and Tsutomu Kameyama and Toshitaka Nabeshima",
year = "1993",
month = "6",
day = "4",
doi = "10.1016/0014-2999(93)90479-2",
language = "English",
volume = "236",
pages = "411--417",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats. / Fuji, Kazuyuki; Hiramatsu, Masayuki; Kameyama, Tsutomu; Nabeshima, Toshitaka.

In: European Journal of Pharmacology, Vol. 236, No. 3, 04.06.1993, p. 411-417.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats

AU - Fuji, Kazuyuki

AU - Hiramatsu, Masayuki

AU - Kameyama, Tsutomu

AU - Nabeshima, Toshitaka

PY - 1993/6/4

Y1 - 1993/6/4

N2 - The effects of repeated propentofylline administration on impairments of learning and memory in rats with basal forebrain lesions were investigated in several behavioral tasks (water maze, habituation and passive avoidance tasks). Rats were subjected to all the tasks in sequence. Basal forebrain lesions produced by bilateral injections of ibotenic acid (approximately 6 μg on each side) severely impaired performance in water maze, habituation and passive avoidance tasks. Repeated administration of propentofylline (10 and 25 mg/kg per day for 14 days, p.o.) improved the deficits of performance in a water maze task, even when administration began one week after the basal forebrain lesions were produced. The impaired performance in habituation and passive avoidance tasks was also markedly ameliorated after repeated administration (24 and 26 days) of propentofylline. The rats with basal forebrain lesions exhibited a significant decrease in choline acetyltransferase activity in the cortex. Propentofylline significantly increased hippocampal choline acetyltransferase activity in basal forebrain-lesioned rats compared with that in vehicle-treated basal forebrain-lesioned rats. However, cortical choline acetyltransferase activity in basal forebrain-lesioned animals was not affected by repeated propentofylline administration. These results indicate that repeated administration of this agent ameliorated the impaired performance of basal forebrain-lesioned rats in part by increasing hippocampal choline acetyltransferase activity. Propentofylline might be useful for the treatment of amensia and dementia.

AB - The effects of repeated propentofylline administration on impairments of learning and memory in rats with basal forebrain lesions were investigated in several behavioral tasks (water maze, habituation and passive avoidance tasks). Rats were subjected to all the tasks in sequence. Basal forebrain lesions produced by bilateral injections of ibotenic acid (approximately 6 μg on each side) severely impaired performance in water maze, habituation and passive avoidance tasks. Repeated administration of propentofylline (10 and 25 mg/kg per day for 14 days, p.o.) improved the deficits of performance in a water maze task, even when administration began one week after the basal forebrain lesions were produced. The impaired performance in habituation and passive avoidance tasks was also markedly ameliorated after repeated administration (24 and 26 days) of propentofylline. The rats with basal forebrain lesions exhibited a significant decrease in choline acetyltransferase activity in the cortex. Propentofylline significantly increased hippocampal choline acetyltransferase activity in basal forebrain-lesioned rats compared with that in vehicle-treated basal forebrain-lesioned rats. However, cortical choline acetyltransferase activity in basal forebrain-lesioned animals was not affected by repeated propentofylline administration. These results indicate that repeated administration of this agent ameliorated the impaired performance of basal forebrain-lesioned rats in part by increasing hippocampal choline acetyltransferase activity. Propentofylline might be useful for the treatment of amensia and dementia.

UR - http://www.scopus.com/inward/record.url?scp=0027195907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027195907&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(93)90479-2

DO - 10.1016/0014-2999(93)90479-2

M3 - Article

C2 - 8359199

AN - SCOPUS:0027195907

VL - 236

SP - 411

EP - 417

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -